BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26744528)

  • 1. Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
    Tanei T; Leonard F; Liu X; Alexander JF; Saito Y; Ferrari M; Godin B; Yokoi K
    Cancer Res; 2016 Jan; 76(2):429-39. PubMed ID: 26744528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions.
    Leonard F; Curtis LT; Yesantharao P; Tanei T; Alexander JF; Wu M; Lowengrub J; Liu X; Ferrari M; Yokoi K; Frieboes HB; Godin B
    Nanoscale; 2016 Jul; 8(25):12544-52. PubMed ID: 26818212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
    Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K
    Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxel.
    Ruttala HB; Ramasamy T; Shin BS; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2017 Mar; 519(1-2):11-21. PubMed ID: 28069389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel.
    Leonard F; Curtis LT; Ware MJ; Nosrat T; Liu X; Yokoi K; Frieboes HB; Godin B
    Front Immunol; 2017; 8():693. PubMed ID: 28670313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
    Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
    Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple breast cancer liver metastases response to macrophage-delivered nanotherapy evaluated via a 3D continuum model.
    Goodin DA; Chau E; Tiwari A; Godin B; Frieboes HB
    Immunology; 2023 Jun; 169(2):132-140. PubMed ID: 36465031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models.
    Chen H; Huang S; Wang H; Chen X; Zhang H; Xu Y; Fan W; Pan Y; Wen Q; Lin Z; Wang X; Gu Y; Ding B; Chen J; Wu X
    Drug Deliv; 2021 Dec; 28(1):1067-1079. PubMed ID: 34109887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
    Tanaka S; Iwamoto M; Kimura K; Matsunami N; Morishima H; Yoshidome K; Nomura T; Morimoto T; Yamamoto D; Tsubota Y; Kobayashi T; Uchiyama K
    Clin Breast Cancer; 2015 Jun; 15(3):191-6. PubMed ID: 25579459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
    Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
    Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer: A retrospective observational study.
    Oi H; Matsuda T; Kimura T; Morise M; Yamano Y; Yokoyama T; Kataoka K; Kondoh Y
    Medicine (Baltimore); 2022 Feb; 101(6):e28863. PubMed ID: 35147134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
    Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
    Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer.
    Roviello G; Conter FU; Mini E; Generali D; Traversini M; Lavacchi D; Nobili S; Sobhani N
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):669-677. PubMed ID: 31187168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases.
    Ceelen W; Sandra L; de Sande LV; Graversen M; Mortensen MB; Vermeulen A; Gasthuys E; Reynders D; Cosyns S; Hoorens A; Willaert W
    EBioMedicine; 2022 Aug; 82():104151. PubMed ID: 35843174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially Overestimated Efficacy of Nanoparticle Albumin-bound Paclitaxel compared with Solvent-based Paclitaxel in Breast Cancer: A Systemic Review and Meta-analysis.
    Li BX; Chen XJ; Ding TJ; Liu YH; Ma TT; Zhang GL; Wang XM
    J Cancer; 2021; 12(17):5164-5172. PubMed ID: 34335933
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of nanoparticle albumin-bound paclitaxel loaded macrophages for glioblastoma treatment based on a microfluidic chip.
    Xie Z; Ye J; Gao X; Chen H; Chen M; Lian J; Ma J; Wang H
    Front Bioeng Biotechnol; 2024; 12():1361682. PubMed ID: 38562665
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.
    Desai NP; Trieu V; Hwang LY; Wu R; Soon-Shiong P; Gradishar WJ
    Anticancer Drugs; 2008 Oct; 19(9):899-909. PubMed ID: 18766004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A patient with paclitaxel hypersensitivity treated with nab-paclitaxel].
    Ouchi A; Ouchi A; Asano M; Aono K; Watanabe T; Kato T
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):889-91. PubMed ID: 25131878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers.
    Liu L; Bi Y; Zhou M; Chen X; He X; Zhang Y; Sun T; Ruan C; Chen Q; Wang H; Jiang C
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):7424-7435. PubMed ID: 28150932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.